trial

Hematological Clozapine Monitoring With a Point-of-care Device (CHEMPAQ)

NCTId NCT01138618
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
Phase — · Completed
Enrollment 85 (actual)
Sponsored by University of Aarhus
Primary completion 2010-12
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Completed
Enrollment
85 (actual)
Study type
Observational
Allocation
—
Model
—
Masking
—
Start
2010-04
Primary completion
2010-12
Eligibility
ALL · 18 Years · 65 Years

Interventions & indications

Drugs
Venous blod sampleCHEMPAQ

Sponsors

University of AarhusLead Sponsor
Aalborg Psychiatric HospitalCollaborator

Investigators

1
Jimmi Nielsen, PhDPrincipal Investigator

Sites

6 total
Greve, DenmarkAalborg, DenmarkAarhus, DenmarkCopenhagen, DenmarkEsbjerg, DenmarkOdense, Denmark

Facts & assertions

4 sourced
Enrollment
85
Phase
NA
Primary Completion Date
2010-12
Status
COMPLETED
relationships
The graph out of here
drug
Venous blod sample
drug
CHEMPAQ
drug
lead_sponsor
University of Aarhus
company
collaborator
Aalborg Psychiatric Hospital
company
indication
Schizophrenia
indication
Schizophrenia
indication
investigator
Jimmi Nielsen, PhD
person